Sign in

Kevin Marchetti

Co-Executive Chairman at Lineage
Executive
Board

About Kevin Marchetti

Co-Founder and Co-Executive Chairman of Lineage, Inc.; age 47. Background includes Managing Partner at Bay Grove since 2007, prior roles at The Yucaipa Companies and Morgan Stanley’s investment banking group in San Francisco; current trustee at the San Francisco Museum of Modern Art and prior board roles at the Pittsburgh Penguins, San Francisco Zoological Society, and International Association of Refrigerated Warehouses . During 2024, the company delivered $5.3B in revenue, expanded margins, increased adjusted EBITDA and AFFO per share, and maintained 78% same-warehouse physical occupancy; initial public market TSR from IPO through year-end implied $72 for a $100 investment, lagging the MSCI US REIT Index peer group at $101 .

Past Roles

OrganizationRoleYearsStrategic Impact
Bay Grove Capital Group LLCManaging Partner; Co-Founder of Lineage’s original owner-operatorSince 2007Long-term investment leadership, M&A, capital strategy for cold storage platform
The Yucaipa CompaniesInvestment professionalPrivate equity/operations experience
Morgan Stanley (Investment Banking, San Francisco)Analyst/AssociateFoundation in capital markets and corporate finance

External Roles

OrganizationRoleYearsStrategic Impact
San Francisco Museum of Modern ArtTrusteeCurrentCultural institution governance and network reach
Pittsburgh PenguinsDirector (prior)Sports franchise governance
San Francisco Zoological SocietyDirector (prior)Non-profit governance
International Association of Refrigerated WarehousesDirector (prior)Industry network and standards

Fixed Compensation

Component (2024)AmountNotes
Board fees (cash)$0Marchetti did not receive director compensation in 2024
Stock awards (RSUs)$0No RSUs granted to Marchetti for board service in 2024
Total$0

Distributions received via legacy ownership interests (BGLH, BG Cold, Bay Grove) are not classified as company-paid compensation; they accrued to entities controlled by Bay Grove and its affiliates and ultimately benefit founders (including Marchetti) through ownership, not director compensation .

Performance Compensation

Not disclosed for Mr. Marchetti. Company-wide incentive design for NEOs in 2024 tied to Management Adjusted EBITDA (70% weighting) and individual objectives (30%), illustrating pay-for-performance alignment at the top of the organization .

MetricWeightThresholdTargetMaximum2024 ActualAchievement
Management Adjusted EBITDA ($MM)70%$1,309.0 $1,400.0 $1,491.0 $1,342.3 95.9%

Equity Ownership & Alignment

ItemValueDetails
Common shares beneficially owned157,406,307Through BG Lineage Holdings and entities
Rights to acquire shares (OP units/OPEUs/RSUs)22,730,773Includes OP units and OPEUs exchangeable into OP units
Total beneficial ownership180,137,080
% of common stock (beneficial)71.7%Based on shares and units outstanding
Shares pledgedNoneNo pledging by directors/executives
OPEUs exchangeabilityTwo years post-IPOOPEUs can be exchanged into OP units after two years (July 2026)
  • Stock ownership policy requires non-employee directors to hold 5x annual cash retainer; executives 3–6x of base salary; compliance required by July 24, 2029 (or 5 years from appointment) .
  • Hedging, short sales, margin purchases, and pledging of company securities are prohibited under insider trading policy .

Employment Terms

  • Non-compete: Restrictive covenants agreement prohibits Marchetti and Forste from competing with Lineage until the earlier of July 26, 2027 or cessation of equity ownership .
  • Stockholders Agreement: As a controlled company founder, Marchetti benefits from director designation rights allocated to BGLH and allied investors; director removal is restricted; company owes founders tax-protective structuring in significant exit transactions and must maintain sufficient debt allocations or offer guarantees to prevent gain recognition; founders retain protections as long as ≥40% of their interest remains (or adjusted basis via death) .
  • Transition Services Agreement: Bay Grove Management contracted to provide capital deployment/M&A support through July 26, 2027 for $8.0M per year (plus expenses); founders indirectly benefit via BG Capital ownership .
  • Registration Rights: BGLH has demand and piggyback rights covering 157,216,306 shares plus 21,248,605 OP units; cash settlements may require company offerings to purchase shares distributed to legacy investors, contributing to potential selling pressure .
  • Clawback: Dodd-Frank/NYSE-compliant policy for recovery of erroneously awarded incentive compensation for Section 16 officers (covers equity awards as well) .

Board Governance

CommitteeRoleIndependence
Nominating & Corporate GovernanceChair: Kevin MarchettiNot independent; committee includes founders (controlled company exemption)
Compensation CommitteeChair: Adam Forste; members include independent directorsNot fully independent under controlled company exemption; Pay Governance engaged as independent advisor
Audit CommitteeChair: Joy Falotico; members Falotico, Wentworth, TurnerFully independent; all financially literate; multiple financial experts
Equity Award CommitteeChair: Lynn Wentworth; members Wentworth, TurnerIndependent; administers Section 16 equity and clawback recoveries
  • Controlled company: Bay Grove affiliates own >50% voting power; Lineage uses Nasdaq “controlled company” exemptions for compensation and nominating/governance committees (not entirely independent) .
  • Lead Independent Director: Lynn Wentworth; responsibilities include presiding over executive sessions, agenda approval, liaison role with CEO and Co-Executive Chairmen .
  • Board attendance: All directors attended ≥75% of board/committee meetings in 2024 .
  • Executive sessions: Independent directors meet at least twice per year in executive session .

Director Compensation

YearCash RetainerCommittee FeesEquityTotal
2024 (Marchetti)$0 $0 $0 $0

Non-employee director program (post-IPO) provides $120,000 annual cash retainer plus committee fees and ~$200,000 annual RSU grants for eligible directors; executive directors and Executive Chairmen are excluded .

Performance & Track Record

MetricFY 2024Notes
Total Revenue ($USD Billions)$5.3Scale across global network
Same-Warehouse Physical Occupancy78%Operational throughput
Value of $100 Investment at IPO (to 12/31/24)$72Company TSR since listing
  • Strategic execution in 2024: Largest U.S. IPO of 2024 and largest REIT IPO ever; leverage reduced to under 5x; earned investment-grade ratings from Moody’s and Fitch .
  • Network and innovation: Patents reached 100; LinOS rollout and automated facilities improved productivity and safety .

Compensation Committee Analysis

  • Independent consultant: Pay Governance advised on executive and director compensation, peer group design, and severance arrangements; committee determined no consultant conflicts .
  • Peer group: REITs and logistics/consumer/transport peers (e.g., Prologis, Equinix, Public Storage, Americold, Old Dominion) used to benchmark pay; 2024 NEO total comp targeted upper quartile based on performance/roles .
  • Governance features: Clawback, stock ownership guidelines, prohibition of hedging/pledging; equity grants not timed around material disclosures .

Say-on-Pay & Shareholder Feedback (2025 AGM)

ProposalForAgainstAbstainBroker Non-Votes
Say-on-Pay (NEO Compensation)185,516,25134,216,03314,8762,847,408
Say-on-Frequency219,399,466 (1 Year)6,311 (2 Years)326,702 (3 Years)14,681

All ten directors (including Marchetti) were re-elected; PwC ratified as auditor .

Equity Overhang & Insider Selling Pressure

  • Coordinated settlements: BGLH will wind down and distribute all shares over up to three years post-IPO, with investors able to elect cash settlements that require company-led repurchases—introducing periodic supply overhang and potential capital allocation impacts .
  • Put Option Agreement: Special redemption/top-up rights for certain legacy equity classes (Legacy Class A-4 OP units) with price floors tied to specified thresholds during the exercise window (Sept 2024–Dec 2025) .
  • No pledging: Founders and directors have not pledged shares; hedging and monetization transactions are prohibited by policy .

Risk Indicators & Red Flags

  • Controlled-company governance: Executive founders chair compensation and nominating committees; independence exceptions raise concerns about objective oversight of pay and director nominations .
  • Related-party economics: Transition services fees ($8M/year through 2027) and historic operating services reimbursements benefit Bay Grove affiliates; founders indirectly benefit via BG Capital ownership .
  • Registration rights & liquidity structures: Demand rights to facilitate cash settlements (157.2M shares + 21.2M OP units) can prompt repurchases/issuances, affecting float and capital priorities .
  • Tax-protection obligations: Stockholders Agreement requires tax-deferred structuring and debt allocation maintenance for founders in significant transactions—may constrain deal structures .

Investment Implications

  • Strong alignment via ownership: Marchetti’s 71.7% beneficial stake embeds long-term alignment but concentrates control, making independent oversight and minority protections critical .
  • Governance risk: Dual executive-chair structure and chairing the nominating committee by a non-independent executive elevates entrenchment risk; rely on the Lead Independent Director and independent Audit/Equity Award Committees as counterbalances .
  • Supply overhang: Planned BGLH distributions and cash settlements, plus special redemption rights, create ongoing insider-driven supply and potential repurchase needs—watch company capital allocation and secondary/structured sale activity .
  • Pay-for-performance indicators: While Marchetti’s individual compensation isn’t disclosed, firm-level incentives and clawback/ownership policies suggest disciplined design for NEOs; 2025 say-on-pay passed, supporting broader compensation approach .
  • Execution track record: 2024 operating milestones (investment-grade ratings, leverage reduction, margin improvements, innovation) validate founder-led strategy; initial public TSR underperformance vs peer index warrants monitoring of post-IPO equity transitions and growth execution .